Highlights and Quick Summary
- Common Stock (Net) for the quarter ending September 30, 2022 was $705 Thousand (a 0.28% increase compared to previous quarter)
- Year-over-year quarterly Common Stock (Net) increased by 3.07%
- Annual Common Stock (Net) for 2021 was $684 Thousand (a 19.37% increase from previous year)
- Annual Common Stock (Net) for 2020 was $573 Thousand (a 684.93% increase from previous year)
- Annual Common Stock (Net) for 2019 was $73 Thousand (a 30.36% increase from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Stock (Net) of Beam Therapeutics Inc.
Most recent Common Stock (Net)of BEAM including historical data for past 10 years.Interactive Chart of Common Stock (Net) of Beam Therapeutics Inc.
Beam Therapeutics Inc. Common Stock (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.71 | $0.7 | $0.7 | – |
| 2021 | $0.68 | $0.68 | $0.65 | $0.62 | $0.68 |
| 2020 | $0.57 | $0.5 | $0.5 | $0.49 | $0.57 |
| 2019 | $0.07 | $0.0 | $0.0 | $0.0 | $0.07 |
| 2018 | – | – | – | $0.06 | $0.06 |
| 2017 | – | – | – | – | $0.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology